<DOC>
	<DOCNO>NCT01157845</DOCNO>
	<brief_summary>The methacetin breath test ( MBT ) non-invasive liver function test measure ability liver metabolize tracer dose compound carbon dioxide , exhale . The study hypothesis measurement MBT allow early detection decline liver function patient cirrhosis await liver transplantation .</brief_summary>
	<brief_title>Use Methacetin Breath Test Predict Liver Failure Patients With Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Inclusion criterion : 1 . Being consider placement already liver transplantation wait list 2 . Cirrhosis cause cause chronic liver disease . 3 . Age &gt; 18 year Exclusion criterion : 1 . Known suspected hepatocellular carcinoma 2 . Prior TIPS placement 3 . Severe congestive heart failure 4 . Severe pulmonary hypertension 5 . Uncontrolled diabetes mellitus ( HBA1C &gt; 9.5 % ) 6 . Any autoimmune disorder , currently treat prednisone immune suppressive medication . 7 . Previous surgical bypass surgery morbid obesity ( BMI &gt; 45 ) 8 . Extensive small bowel resection 9 . Patients currently receive total parenteral nutrition contraindication oral drug 10 . Women pregnant 11 . Patients allergic acetaminophen/ paracetamol relate medication 12 . Patients acute current exacerbation chronic obstructive pulmonary disease bronchial asthma . 13 . Patients take hepatotoxin drug 14 . Patient , base opinion investigator , enrol study 15 . Patient unable unwilling sign inform consent . 16 . Patients participate clinical trial evaluate experimental treatment procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>